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Egletes viscosa Less (Asteraceae), popularly known as “macela” or
“macela-da-terra”, is a plant widely used in popular medicine due to
its anti-inflammatory, bactericidal, antidiarrhoea, mio-relaxant,
antispasmodic, antinociceptive, digestive, and anti-viral properties.
Phytochemical screening of aqueous extract of Egletes viscosa (AEEV)
revealed the high presence of flavonoids. This study examined the oral
antinociceptive potential of AEEV in rodents using different
concentrations (100, 200, and 400 mg/kg, p.o.). The results showed
significant antinociceptive action when tested in writhing (200 and
400 mg/kg-p<0.05) and in the second phase of formalin tests
(200 mg/kg-p<0.01 and 400 mg/kg-p<0.001). The inhibition (%) of
extract in the writhing test was 63.4, 56.7, and 79.2% respectively for
200, 400, and acetyl salicylic acid (300 mg/kg); for the formalin test
(second phase) results were 66.1, 84.7, and 96.2% respectively for 200,
400, and acetyl salicylic acid (300 mg/kg). Collectively, these
observations suggest that AEEV is effective against continuous
inflammatory pain. AEEV was well tolerated. In an acute toxicity test,
oral administration of 5 g/kg of AEEV was performed and no mortality
rate was observed. Similarly, in a subchronic toxicity study, no mortality
was observed after 30 days of daily oral administration of 100 mg/kg of
AEEV. There was no significant difference in the body and organ weights
between control and experimental animals in both acute and subchronic
toxicity tests. Pathological assays did not reveal any evidence of
detectable differences in the gross appearance, as well as in the
architectural or cellular pattern characteristics of the internal organs
of the animals in both acute and subchronic tests. Nevertheless,
significant differences were verified between males of the experimental
and control groups regarding the levels of hemoglobin and leukocytes.
In conclusion, AEEV did not induce any hazardous effects on the majority
of the parameters studied. Additionally, an antinociceptive activity of
the extract was verified. However, the increase in the levels of hemoglobin
and leukocytes should be investigated in more detail.
*Correspondence:
A. A. S. Araújo
Departamento de Fisiologia
Universidade Federal de Sergipe
Av. Marechal Rondom, s/n
49000-000 - São Cristóvão – SE, Brasil
E-mail: adriasa2001@yahoo.com.br
Uniterms
• Egletes viscose
• pharmacognosy
• Egletes viscose/
• experimental study
• Egletes viscose/
• antinociception effect
• Phytochemical screening
A.A.S. Araújo, L.R. Bonjardim, É.M. Mota, R.L.C. Albuquerque-Júnior, C.S. Estevam, L. Cordeiro, S.R. S. Seixas708
INTRODUCTION
Egletes viscosa Less (Asteraceae), popularly known
as “macela”, is an annual herbal plant used in Brazilian po-
pular medicine (Lima et al., 1996). Due to its large
household use for the preparation of a tea - to which
emmenagogue, diaphoretic stomachic, and antidiarrhoea
properties seem to be related - dried flower buds of E. vis-
cosa are widely sold in herbal stores and supermarkets of
the Brazilian northeast (Vieira et al., 2006). Amongst its
applications, pharmacological studies showed anti-
hepatotoxic (Rao et al., 1994), antiperoxidative (Souza et
al., 1997), gastroprotective and antidiarrhoeal (Rao et al.,
1997), hepatoprotective (Souza et al . ,  1998a),
antithrombotic (Souza et al., 1994), and anti-anaphylactic
and anti-inflammatory (Souza et al., 1992; Rao et al.,
2003) properties for ternatin; antinociceptive and
gastroprotective for the diterpenes (Guedes et al., 2002),
and antinociceptive, anticonvulsant, and antibacterial
activities for the essential oil (Souza et al., 1998b). Its na-
tural habitat is South America, blossoming spontaneously
in Uruguay, Paraguay, and in the south of Brazil. In Rio
Grande do Sul it grows abundantly in wild herbal form, as
much in arenaceous soil as in basaltic soil.
The use of herbal medicines or natural health
products as alternative medicines for public health use
continues to expand rapidly around the world. Pre-clinical
assays are essential to guarantee the efficacy and safety of
natural products and are commonly requested by regulatory
agencies to approve marketing of these products (Remirez,
2006). In addition, the National Agency of Sanitary
Surveillance (Agência Nacional de Vigilância Sanitária/
ANVISA) of Brazil published on February 24, 2000,
Resolution nº 17 (Brasil, 2000) establishing that
phytomedicines should be submitted to pre-clinical and
clinical toxicological and pharmacological assays in order
to ensure the quality and safety of their use.
The aim of this present study was to evaluate the
antinociceptive potential and toxicity of the aqueous extract
of Egletes viscosa (AEEV).
MATERIALS AND METHODS
Plant material
The seeds of E. viscosa Less (Asteraceae) were
collected from the campus of the Federal University of
Sergipe, Sergipe State, Brazil, in December 2004 and were
identified by Dr. Ana Paula Prata (DBI/UFS). A voucher
specimen (nº 1066) is deposited at the Herbarium of the
Federal University of Sergipe.
Preparation of the plant extract
An aqueous extract was obtained from the seeds of
the E. viscosa harvested from the campus of the Federal
University of Sergipe. After harvesting the seeds of the E.
viscosa, they were adequately selected and then submitted
to drying in a sterilizer with hot air circulation and renewal
(Model MA-037) at 37 ºC until complete dehydration.
Subsequently, the seeds were weighed and triturated in an
electric mill until a dust of fine granulation was obtained.
The aqueous crude extract of the seeds was prepared by
adding 1000 mL of distilled water to 50 g of seed powder
and kept at 77 ºC for 30 min. Two extractions were
performed to fully extract the plant material. Then, the
extract was vacuum-filtered, lyophilized, and stored in the
dark at 8 ºC. At the moment of use the extract was dissolved
in water at the desired concentration.
Phytochemical screening
The aqueous extract was divided into different test
tubes and various chemical constituents were qualitatively
analyzed according to methods described by Matos (1994),
and Harbone (1998). This analysis was conducted by
observing colorimetric variation after the addition of
specific reagents. The different chemical constituents and
reagents tested included: catechins, xanthones, flavonoids,
and flavononols - acid-alcohol/solid magnesium, ferric
chloride reagents; saponin-frothing test.
Animals
Male and female Swiss mice (Mus muscullus)
weighing 30-45 g were obtained from Tiradentes University
(Sergipe, Brazil). For toxicological tests both male and
female mice were used, and for nociceptive tests only male
mice were used. The animals were kept under conventional
conditions of temperature (20 ± 2 ºC) and lodged in
polypropylene cages, with food and water ad libitum. Expe-
rimental protocols were approved by the Committee on Ani-
mal Research at the Federal University of Sergipe
(nº 05/2007) and conformed to the International Association
for the Study of Pain (IASP) guidelines for the study of pain
in animals (Zimmermann, 1983). The experiments were
performed in the time period of 1:00 p.m. to 6:00 p.m.
Behavioral screening
This test was used in order to check for possible ge-
neral central nervous system effects of the AEEV. Four
groups of 8 mice were treated with saline (10 mL/kg, p.o.)
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or the AEEV at the doses of 100, 200, and 400 mg/kg (p.o.,
at a single dose). Animals were observed for 4 h and their
behaviors were recorded at 30, 60, 120, 180, and 240 min
after the treatment. Specific behaviors (sedation,
ambulation, response to touch, analgesia, and defecation)
and their intensities were observed according to Almeida et
al. (1999).
Analgesic activity
Acetic acid-induced abdominal constriction (Writhing
test)
This test was done using the method described by
Koster et al. (1959) and Broadbear et al. (1994). Muscular
contractions were induced by intraperitoneal injection (ip) of
a 0.85 % solution of acetic acid (0.25 mL/animal) to a group
of 8 mice. The number of muscular contractions was counted
for 15 min after injection and the data represents the average
of the total number of writhes observed. The AEEV (100,
200, and 400 mg/kg) or the acetylsalicilic acid reference drug
(ASA), in doses of 300 mg/kg, were administered orally 1 h
before the acetic acid injection.
Formalin test
The observation chamber was a glass box of 30 cm
diameter on a transparent acrylic plate floor. Beneath the
floor, a mirror was mounted at a 45° angle to allow clear
observation of the paws of the animals. The animals
(n=8/per group) were treated with the vehicle (Saline),
AEEV (100, 200, and 400 mg/kg, p.o.), or ASA (300 mg/
kg) 1 h before formalin injection. Each mouse was placed
in the chamber more than 5 min before treatment in order
to allow acclimatization to the new environment. The
formalin test was carried out as described by Hunskaar and
Hole (1987). Twenty microliters of a 2.5% formalin
solution (0.92% formaldehyde) in a phosphate-buffer were
injected in the dorsal surface of the left hind paw using a
microsyringe with a 26-gauge needle. Each animal was
then returned to the chamber and the amount of time that the
animal spent licking the injected paw was considered as
indicative of pain. Two distinct phases of intensive licking
activity were identified: an early acute phase (0-5 min/
phase 1) and a late or tonic phase (15-30 min/phase 2).
Toxicological studies
Acute toxicity study
The animals were distributed in four groups (n=6 per
group) and kept in adequately maintained boxes, which had
been previously named as box I and II (composed of male
and female control groups, respectively) and boxes III and
IV (composed of male and female experimental groups).
The animals were submitted to crescent doses (1, 3, and
5 g/kg) managed by oral administration (gavage), adopting
5 g/kg as the maximum dose to be used.
Specific behaviors (sedation, ambulation, response to
touch, analgesia, and defecation) and their intensities were
observed according to Almeida et al. (1999) for 1, 2, 3, and
4 h after gavage. Finally, the animals were observed daily
for 14 days to verify lethality.
Subchronic toxicity study
Toxicological assays were performed with 12 male
and 12 female mice, whose weights ranged from 30 to
45 g, distributed in 4 groups of 6 animals (experimental and
control groups of male and female mice). For the
subchronic study, daily doses of the extract (100 mg/kg)
were given to the experimental groups over a period of
30 days, while only water was given to the control group.
Subsequently, the animals were sacrificed and a detailed
study of gross and microscopic features of internal organs,
as well as hematological and biochemical analyses of blood
were carried out. The position, shape, size, texture,
consistency, and color of internal organs (lungs, heart, liver,
intestines, and kidneys) were macroscopically observed
looking for any signs of gross changes These organs were
then collected, weighed to determine relative organ weights,
and preserved in 10% phosphate buffered formalin solution
for subsequent histological procedures.
Parameters
Hematological analysis
All surviving animals fasted overnight and were
anesthetized afterwards for blood collection from a
common carotid artery. Blood samples were collected into
heparinized and dry non-heparinized centrifuge tubes.
Blood (1mL) from the mice was collected from the carotid
artery into syringes and immediately analyzed for the
estimation of number of erythrocytes (106/mm3),
hemoglobin (Hb, g/%), hematocrit (packed cell volume,
%), the mean corpuscular volume (MCV, mcm3), the mean
corpuscular hemoglobin (MCH, mmg), the mean
corpuscular hemoglobin concentration (MCHC, %), and
total white blood cells (WBCs): lymphocytes, leucocytes
(p/mm3), segmented, eosinophils, neutrophils, and
monocytes.
Tissue analysis
Formalin-fixed samples of the internal organs were
dehydrated, diafanized, and embedded in paraffin
according to routine protocol of histological procedures.
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Five micrometer thin sections of the paraffin-embedded
tissues were obtained and stained by means of hematoxilin-
eosin histochemical method. Morphological analysis of the
histological sections was performed by light microscopy
following a closed numerical protocol in such a manner as
the pathologist was not aware of what group was being
evaluated until the end of the experiment.
Statistical analysis
Both analysis of variance (ANOVA) and Student´s t-
test (Origin 6.2 computer program) were employed to carry
out the statistical analysis of the results. All values were
expressed as back transformed mean ± standard deviation.
Differences below the probability level of 0.05 were
considered statistically significant. The percent of
inhibition by an antinociceptive agent was determined for
each experimental group using the following formula
(Reanmongkol et al., 1994):
inhibition % = 100 . (control-experiment)/control
RESULTS AND DISCUSSION
Phytochemical tests
Phytochemical screening of the AEEV showed the
presence of saponin, catechins, flavonoids, flavononols,
and xanthones. The number of positive signs indicated high
quantity flavonoids (Table I).
Analgesic activity
Writhing test
The number of writhes during the 15 min test period
was statistically lower in doses of 200 (p<0.05) and
400 mg/kg (p<0.05) of AEEV than in the control group (Fi-
gure 1). Although these results are significant, the inhibition
(%) of nociceptive behavior by the 200 and 400 mg/kg
(63.4 and 56.7%) doses was inferior to that produced by the
reference drug, ASA-300 mg/kg (79.2%).
The AEEV inhibited acetic acid-induced writhing in
mice. In acetic acid-induced abdominal writhing, pain is
elicited by the injection of an irritant such as acetic acid into
the peritoneal cavity which produces episodes of characteristic
stretching (writhing) movements, and the inhibition of the
number of episodes by analgesics is easily quantifiable.
Despite the significant results obtained, the abdomi-
nal writhing test model has been reported to be a less
selective model. In the writhing test, both central and
peripheral analgesics can be detected because of the lack of
specificity (Abdollahi et al., 2003). Thus, caution is
required in interpreting the results and other tests should be
performed.
Formalin test
In the first phase AEEV did not show any significant
effect on nociception (Figure 2). Oral administration of
AEEV, in doses of 200 (p < 0.01) and 400 mg/kg (p <
0.001), reduced statistically pain in the second phase of the
formalin test, as shown in Figure 3. This decrease occurred
in a dose dependent manner. Moreover, the inhibition % by
200 and 400 mg/kg extracts was inferior to that produced
by the reference drug-ASA-300 mg/kg (66.1, 84.7, and
96.2 % respectively).
A subcutaneous injection of formalin produces a
distinct biphasic nociception. The first phase starts
immediately after the formalin injection and continues for
5 min, after which nociception appears to diminish. The
second phase begins as a return to high levels of nociception
beginning 15~30 min after the formalin injection and con-
tinues for 60 min (Hunskaar, Hole, 1987). These phases
have obvious, different properties and are very useful tools,
not only for assessing the potency of analgesics, but also for
elucidating the mechanisms of pain and analgesia. The
action of analgesics is different in the first and second
TABLE I - Phytochemical screening of aqueous extract of
Egletes viscosa
Parameters Extract
Colour Reddish brown
Catechins +
Saponin +
Flavonoids + + +
Flavononols +
Xanthones +
+ Positive test; +++ quantitative presence.
FIGURE 1 - Antinociceptive effects of aqueous extract of
Egletes viscosa on acetic acid-induced abdominal writhes.
Values are significant at *P <  0.05; **P < 0.001 vs. saline
+ extract; ANOVA+Dunnet.
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phases. Drugs such as narcotics (e.g. morphine, codeine,
meperidine) which primarily act centrally, inhibit both
phases equally (Hunskaar et al., 1985; Shibata et al., 1989;
Vaccarino et al., 1989; Chen et al., 1995), but peripherally
acting drugs such as aspirin, oxyphenbutazone,
dexamethasone, and hydrocortisone only inhibit the second
phase of formalin-induced nociception (Shibata et al.,
1989; Chen et al., 1995). In the present study, AEEV only
inhibits the second phase of the formalin test, although
during behavioral screening the highest dose of AEEV
showed depressant activity. Flavonoids were found to be
the main component of this extract, which could explain its
analgesic effects. It has been reported that flavonoids may
interact directly with the prostaglandin system (Panthong
et al., 1989; Recio et al., 1995). In addition, Rao et al.
(2003) reported that ternatin, a flavonoid from Egletes vis-
cosa Less, exerts its anti-inflammatory action, at least in
part, through inhibition of neutrophil migration and
modulation of macrophage function.
Toxicological studies
The tests for acute toxicity from the aqueous extract
of E. viscosa did not demonstrate signs of lethality in mice
until the maximum dose of 5 g/kg was given by oral
administration. A 5 g/kg body weight dose was considered
as the “Limit test”, as recommended by acute toxicity
testing procedures. Therefore, administration of further
higher doses was considered physiologically unsound and
is not generally recommended (Muralidhara et al., 1999;
Barros et al., 2005). In regard to behavioral screening, the
aqueous extract of E. viscosa at a dose of 400 mg/kg (p.o.)
produced sedation, a decrease of ambulation, and a
reduction of response to touch, analgesia, and a decrease of
defecation. However, at doses of 100 and 200 mg/kg (p.o.)
no major effects on the nervous system were revealed.
Thus, the highest dose of AEEV was indicative of
depressive activity on the CNS according to Almeida et al.
(1999). Nevertheless, it is necessary to determine the ma-
jor evidence indicating depressant activity as well as the
possible action mechanisms (Franco et al., 2005).
Oral administration of E. viscosa seed extract for
30 days did not cause any appreciable alterations in water
and food intake in any of the groups. Moreover, body weight
gain during the observation period among the treated animals
(experimental groups) was comparable to their respective
control group (p>0.05). The body weights of all animals
were measured every week throughout the study (Fig. 4).
At necropsy, no significant changes in the vital organ
weights were seen in any of the male and female mice
FIGURE 2 - Antinociceptive effects of aqueous extract of
Egletes viscosa on first phase of the formalin test
FIGURE 3 - Antinociceptive effects of aqueous extract of
Egletes viscosa on second phase of the formalin test. Values
are significant at *P< 0.01; **P<0.001 vs. control;
ANOVA+Dunnet
FIGURE 4 - Body weight curves for male and female mice
treated with aqueous extract of Egletes viscosa or saline
solution for 30 days.
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treated with aqueous extract of E. viscosa as compared
with the control groups (p > 0.05) (Table II). These results
clearly indicate that AEEV does not interfere in the normal
weight of the available organs.
The administration of oral doses of the AEEV did not
cause erythrocyte, hematocrit, MCV, MCH, MCHC,
segmented neutrophils, eosinophils, lymphocytes, and
monocytes serum levels to change (Table III and Table IV).
However, a significant increase in hemoglobin and leukocyte
values was observed for the male experimental group (p <
0.05) when compared to the male control group. This
significant difference was not verified between the females
groups. In addition, no evidence of changes in body weight and
animal behavior, as well as in the histological architecture of
the internal organs, was found. Therefore, these outcomes
suggested the absence of any hematotoxic potency of AEEV,
although the increase in levels of hemoglobin and leukocytes
should be investigated in more detail.
Pathological examination of the tissues on a gross
basis indicated that there were no detectable abnormalities,
neither in weight nor in appearance, and no significant
differences were grossly detected between control and ex-
perimental groups. Moreover, the organs of both groups
were unremarkable and comparable to each sex.
Microscopical analysis of the examined internal organs
revealed that their architectural and cellular appearance
were comparatively unremarkable in both groups and
sexes. Nevertheless, all pulmonary samples from both ex-
TABLE III - The effect of aqueous extract of Egletes viscosa on differential count of blood (red series) of the sub-chronic
study. (mean±SD)
Values Erythrocytes Hemoglobin Hematocrit MCV MCH MCHC
(milh/mm3) (g/%) (%) (mcu3) (uug) (%)
CM 5.18 ± 0.7 8.70 ± 0.4 27.60 ± 3.4 52.35 ± 2.9 16.63 ± 1.7 31.77 ± 2.9
TM 6.34 ± 1.0 10.30 ± 1.2* 33.10 ± 6.3 52.09 ± 2.0 16.35 ± 1.0 31.45 ± 2.6
CF 4.85 ± 1.9 8.90 ± 2.5 28.65 ± 8.9 61.70 ± 9.9 19.46 ± 3.1 31.57 ± 2.1
TF 6.28 ± 0.36 9.90 ± 0.65 33.76 ± 2.0 53.70 ± 0.5 15.76 ± 0.3 29.32 ± 0.8
CM (control male), TM (treated male), CF (control female) and TF (treated female). MCV- Mean Corpuscular Volum,
MCH- Mean Corpuscular Hemoglobin, MCHC- Mean Corpuscular Hemoglobin Concentration * Values are significant
at P< 0.05 vs. control; Student´s t-test.
TABLE IV - The effect of aqueous extract of Egletes viscosa on differential count of blood (white series) of the sub-chronic
study. (mean±SD)
Leukocytes (p/mm3) Neutrophils Eosinophils Lymphocytes Monocytes
CM 1.233 ± 450 25 ± 3.3 0.50 ± 0.6 71.0 ± 2.8 3.0 ± 0.8
TM 2.266 ± 926* 32 ± 6.9 0.50 ± 0.5 63.0 ± 6.4 3.0 ± 0.8
CF 2.250 ± 858 42 ± 6.4 1.25 ± 0.5 52.5 ± 6.5 3.5 ± 0.6
TF 1.300 ± 264 34 ± 9.6 1.33 ± 1.1 61.6 ± 10 3.0 ± 0.0
CM (control male), TM (treated male), CF (control female) and TF (treated female). * Values are significant at P< 0.05
vs. control; Student´s t-test.
TABLE II - Organs weight for male and female mice treated with aqueous extract of Egletes viscosa or saline solution for
30 days
Organ weights
Group  Lungs (mg) Heart (mg) Liver (mg) Kidneys (mg)
CM 253 ± 47 206 ± 23 1800 ± 0.12 512.7 ± 60.2
TM 218 ± 33 198 ± 17 1830 ± 0.06 521.9 ± 63.9
CF 205 ± 39 161 ± 8 1540 ± 0.18 345.4 ± 33.5
TF 249 ± 26 187 ± 33 1720 ± 0.43 372.5 ± 43.1
* CM (controlled male), TM (treated male), CF (controlled female) and TF (treated female).
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perimental and control groups revealed a picture of slight
and focal atelectasy. This morphological alteration might
have been a result of some already expected changes in their
blood pressure and respiratory rhythm, probably due to the
conditions of continuous stress caused by experimental
manipulation of the animals. Therefore, it seems absolutely
clear that the focal morphological picture of atelectasy is
not related to the aqueous extract of E. viscosa Less oral
administration, as it was observed in both experimental and
control groups.
CONCLUSION
It is concluded that the aqueous extract of Egletes
viscosa did not induce any hazardous effects on the
majority of the parameters studied and showed
antinociceptive properties. The extract will, therefore, be of
potential benefit in the management of inflammatory pain
disorders. Further studies currently in progress will enable
as to understand the mechanisms of action underlying the
effects observed in this investigation. In acute and
subchronic toxicity tests no mortality rate was observed.
There was no significant difference in the body and organ
weights between control and experimental animals in both
acute and subchronic toxicity tests. Pathological assays did
not reveal any evidence of detectable differences in the
gross appearance, as well as in the architectural or cellular
pattern characteristics of the internal organs of the animals
in both acute and subchronic tests.
RESUMO
Atividade antinociceptiva e estudo toxicológico de
extrato aquoso de Egletes viscosa Lessa (Asteraceae)
Egletes viscosa Less (Asteraceae), popularmente conhe-
cida como “macela” ou “macela-da-terra”, é uma planta
largamente usada na medicina popular devido as suas
propriedades: anti-inflamatória, bactericida,
antidiarréica, mio-relaxante, anti-espasmódica,
antinociceptiva, digestiva e anti-viral. Análise fitoquímica
do extrato aquoso da Egletes viscosa (AEEV) mostrou
elevada presença de flavonóides. Este estudo examinou o
potencial antinociceptivo do AEEV em roedores usando
diferentes concentrações (100, 200 and 400 mg/kg, p.o.).
Os resultados mostraram significante efeito
antinociceptivo quando testadas as doses (200 mg/kg-
p<0.01; 400 mg/kg-p<0.05) e na segunda fase dos testes
com formalina (200 and 400 mg/kg-p<0.001). Este efei-
to antinociceptivo foi similar ao ácido acetilsalicílico
(300 mg/kg) nas doses de 200 e 400 mg/kg. Adicionalmen-
te, estas observações sugerem que o AEEV é efetivo con-
tra dores inflamatórias contínuas. AEEV foi bem tolera-
da. No teste de toxicidade aguda, utilizando uma adminis-
tração oral de 5 g/kg de AEEV, não foi observado casos de
mortalidade. Da mesma maneira, no estudo subcrônico
nenhuma mortalidade foi observada após 30 dias de ad-
ministração oral diária de 100 mg/kg do AEEV. Não hou-
ve diferença significativa entre os pesos corporal e dos ór-
gãos isolados quando comparados grupo controle e tes-
te tanto no estudo agudo quanto subcrônico. Ensaios
histopatológicos não revelaram diferenças entre a apa-
rência dos tecidos, assim como na estrutura celular dos
órgãos dos animais do estudo agudo e subcrônico. No en-
tanto, diferenças significativas foram verificadas entre os
machos do grupo experimental e controle quanto à
hemoglobina e leucócitos. Conclui-se que o extrato estu-
dado não induziu nenhum risco na maioria dos
parâmetros avaliados e, ainda, mostrou efeito
antinociceptivo. No entanto, o aumento dos níveis de
hemoglobina e leucócitos devem ser melhor investigados.
UNITERMOS: Egletes viscosa/farmacognosia. Egletes
viscosa/estudo experimental. Egletes viscosa/ efeito
antinocicepitivo. Triagem fitoquímica.
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